Welcome to LookChem.com Sign In|Join Free
  • or
Androst-5-en-3-ol-7,17-dione acetate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1449-61-2

Post Buying Request

1449-61-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1449-61-2 Usage

Chemical Properties

White to off-white crystalline powder

Check Digit Verification of cas no

The CAS Registry Mumber 1449-61-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,4 and 9 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1449-61:
(6*1)+(5*4)+(4*4)+(3*9)+(2*6)+(1*1)=82
82 % 10 = 2
So 1449-61-2 is a valid CAS Registry Number.
InChI:InChI=1/C21H28O4/c1-12(22)25-14-6-8-20(2)13(10-14)11-17(23)19-15-4-5-18(24)21(15,3)9-7-16(19)20/h11,14-16,19H,4-10H2,1-3H3

1449-61-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name [(8R,9S,10R,13S,14S)-10,13-dimethyl-7,17-dioxo-2,3,4,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate

1.2 Other means of identification

Product number -
Other names 3-ACETYL-7-OXO-DHEA

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1449-61-2 SDS

1449-61-2Synthetic route

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

acetic anhydride
108-24-7

acetic anhydride

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

Conditions
ConditionsYield
With toluene-4-sulfonic acid for 0.0333333h; microwave irradiation;96%
for 3h; Reflux;85%
prasterone acetate
853-23-6

prasterone acetate

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

Conditions
ConditionsYield
With N-hydroxyphthalimide; sodium dichromate; chromium(III) perchlorate In water; acetonitrile at 20℃; for 48h; Product distribution / selectivity;93%
With tert.-butylhydroperoxide; N-hydroxyphthalimide; cobalt(II) acetate In acetone at 20℃; for 5h; regioselective reaction;93.7%
Stage #1: prasterone acetate With tert.-butylhydroperoxide; 3 A molecular sieve In decane; ethyl acetate at 20℃; for 0.5h;
Stage #2: With manganese triacetate In decane; ethyl acetate at 20℃; for 30h;
91%
prasterone acetate
853-23-6

prasterone acetate

A

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

B

3β,5-dihydroxy-5α-androstane-6,17-dione 3-acetate
39933-10-3

3β,5-dihydroxy-5α-androstane-6,17-dione 3-acetate

C

3β-acetoxy-5β,6β-epoxyandrostan-17-one
6585-68-8

3β-acetoxy-5β,6β-epoxyandrostan-17-one

Conditions
ConditionsYield
With chromyl acetate In dichloromethane at -78℃; for 0.25h;A 30 mg
B 60 mg
C 77%
prasterone acetate
853-23-6

prasterone acetate

A

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

B

7α-hydroxy-17-oxoandrost-5-ene-3β-yl acetate
37976-94-6

7α-hydroxy-17-oxoandrost-5-ene-3β-yl acetate

Conditions
ConditionsYield
With tert.-butylhydroperoxide; manganese(IV) oxide In dichloromethane; water at -20℃; for 22h; Reflux; regioselective reaction;A 75%
B 13%
prasterone acetate
853-23-6

prasterone acetate

A

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

B

(3S,6aR,6bS,9aS,11aS,11bR)-9a,11b-dimethyl-9-oxohexadecahydrocyclopenta[1,2]phenanthro[8a,9-b]oxiren-3-yl acetate
929270-02-0

(3S,6aR,6bS,9aS,11aS,11bR)-9a,11b-dimethyl-9-oxohexadecahydrocyclopenta[1,2]phenanthro[8a,9-b]oxiren-3-yl acetate

Conditions
ConditionsYield
With tert.-butylhydroperoxide; chromium(VI) oxide In dichloromethane for 24h; Ambient temperature;A 52%
B 8%
prasterone acetate
853-23-6

prasterone acetate

A

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

B

7α-hydroxy-17-oxoandrost-5-ene-3β-yl acetate
37976-94-6

7α-hydroxy-17-oxoandrost-5-ene-3β-yl acetate

C

3β-acetoxy-5β,6β-epoxyandrostan-17-one
6585-68-8

3β-acetoxy-5β,6β-epoxyandrostan-17-one

D

5α,6α-epoxy-17-oxoandrostan-3β-yl acetate
14545-93-8

5α,6α-epoxy-17-oxoandrostan-3β-yl acetate

Conditions
ConditionsYield
With ferric picolinate complexes; dihydrogen peroxide In acetonitrile for 3h; Ambient temperature;A 22%
B 39.3%
C 1.9%
D 0.7%
With ferric picolinate complexes; dihydrogen peroxide In acetonitrile for 3h; Ambient temperature;A 22%
B 39.3%
C 1.9%
D 0.7%
3β-acetoxy-17-picolinylidene-androst-5-ene
84412-82-8

3β-acetoxy-17-picolinylidene-androst-5-ene

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

Conditions
ConditionsYield
With chromium(VI) oxide In acetic anhydride; acetic acid at 90 - 95℃; for 1h;10.6%
3β-acetoxy-17-picolinylidene-androst-5-ene
84412-82-8

3β-acetoxy-17-picolinylidene-androst-5-ene

A

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

B

3β-acetoxy-17-picolinylidene-5-androstene-7-one
83830-40-4

3β-acetoxy-17-picolinylidene-5-androstene-7-one

Conditions
ConditionsYield
With chromium(VI) oxide In water; acetic acid at 90 - 95℃; for 1h;A 9.8%
B 8.9%
prasterone acetate
853-23-6

prasterone acetate

A

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

B

3β-acetoxy-5β,6β-epoxyandrostan-17-one
6585-68-8

3β-acetoxy-5β,6β-epoxyandrostan-17-one

C

5α,6α-epoxy-17-oxoandrostan-3β-yl acetate
14545-93-8

5α,6α-epoxy-17-oxoandrostan-3β-yl acetate

Conditions
ConditionsYield
With Mn(OTf)2(dMMpdp); dihydrogen peroxide; trimethylpyruvic acid In water; ethyl acetate; acetonitrile at 20℃; for 1h; Reagent/catalyst; diastereoselective reaction;A 8%
B n/a
C n/a
With Fe(OTf)2(dMMpdp); dihydrogen peroxide; trimethylpyruvic acid In water; ethyl acetate; acetonitrile at 20℃; for 1h; diastereoselective reaction;A 2%
B n/a
C n/a
prasterone acetate
853-23-6

prasterone acetate

A

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

B

3β-acetoxy-5,20-dioxo-5,6-secoandrostan-6-oic acid
98128-97-3

3β-acetoxy-5,20-dioxo-5,6-secoandrostan-6-oic acid

Conditions
ConditionsYield
With chromium(VI) oxide; acetic acid
3β-acetoxy-7α-azidoandrost-5-en-17-one
27270-51-5

3β-acetoxy-7α-azidoandrost-5-en-17-one

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

Conditions
ConditionsYield
With lead(IV) acetate; trimethylsilylazide
androstenediol-3-acetate
1639-43-6

androstenediol-3-acetate

A

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

B

3β-acetoxy-17β-hydroxy-5-androsten-7-one
55935-02-9

3β-acetoxy-17β-hydroxy-5-androsten-7-one

Conditions
ConditionsYield
With tert.-butylhydroperoxide; copper(l) iodide In decane; acetonitrile at 50℃; for 24h; Title compound not separated from byproducts;A n/a
B 70 % Spectr.
With tert.-butylhydroperoxide; cobalt(II) acetate In decane; acetonitrile at 55℃; for 24h;A n/a
B 70 % Spectr.
prasterone acetate
853-23-6

prasterone acetate

A

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

B

3β,6α-diacetoxy-5-hydroxy-5α-androstan-17-one
528870-28-2

3β,6α-diacetoxy-5-hydroxy-5α-androstan-17-one

C

3β-acetoxy-5β,6β-epoxyandrostan-17-one
6585-68-8

3β-acetoxy-5β,6β-epoxyandrostan-17-one

D

5α,6α-epoxy-17-oxoandrostan-3β-yl acetate
14545-93-8

5α,6α-epoxy-17-oxoandrostan-3β-yl acetate

Conditions
ConditionsYield
With potassium permanganate; sodium perborate; acetic acid Ambient temperature;A 30 mg
B 73 mg
C 292 mg
D 67 mg
prasterone acetate
853-23-6

prasterone acetate

acetic acid
64-19-7

acetic acid

A

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

B

3β,6α-diacetoxy-5-hydroxy-5α-androstan-17-one
528870-28-2

3β,6α-diacetoxy-5-hydroxy-5α-androstan-17-one

C

3β-acetoxy-5β,6β-epoxyandrostan-17-one
6585-68-8

3β-acetoxy-5β,6β-epoxyandrostan-17-one

D

5α,6α-epoxy-17-oxoandrostan-3β-yl acetate
14545-93-8

5α,6α-epoxy-17-oxoandrostan-3β-yl acetate

Conditions
ConditionsYield
With potassium permanganate; sodium perborate Ambient temperature;A 30 mg
B 73 mg
C 292 mg
D 67 mg
acetic anhydride
108-24-7

acetic anhydride

3β-hydroxy-androstene-(5)-dione-(7.17)

3β-hydroxy-androstene-(5)-dione-(7.17)

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

Conditions
ConditionsYield
With pyridine
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

acetic anhydride
108-24-7

acetic anhydride

A

3β,7α-diacetoxyandrost-5-en-17-one
2863-23-2

3β,7α-diacetoxyandrost-5-en-17-one

B

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

C

3β,7α,17β-triacetoxyandrost-5-ene

3β,7α,17β-triacetoxyandrost-5-ene

Conditions
ConditionsYield
Stage #1: dehydroepiandrosterone With fungus Fusarium oxysporum var. cubense In ethanol at 27℃; for 180h; biotransformation; Acetylation; Microbiological reaction; fungus from rhizome of banana plant showing symptoms of Panama disease;
Stage #2: acetic anhydride With pyridine at 60℃;
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: acetic acid; sodium acetate / 18 h / 65 °C
1.2: 94 percent / H2O / 4 h / 20 °C
View Scheme
aqueous sodium hypochlorite

aqueous sodium hypochlorite

dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

prasterone acetate
853-23-6

prasterone acetate

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

Conditions
ConditionsYield
With tert.-butylhydroperoxide; sodium hydroxide; sodium acetate; sodium sulfite In water; acetic anhydride; ethyl acetate
dehydroepiandrosterone
53-43-0

dehydroepiandrosterone

A

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

B

7α-hydroxy-17-oxoandrost-5-ene-3β-yl acetate
37976-94-6

7α-hydroxy-17-oxoandrost-5-ene-3β-yl acetate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine
2: tert.-butylhydroperoxide; manganese(IV) oxide / water; dichloromethane / 22 h / -20 °C / Reflux
View Scheme
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

3β-Acetoxy-7,17-dioxo-5α-androstan
13258-27-0

3β-Acetoxy-7,17-dioxo-5α-androstan

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In tetrahydrofuran at 25℃; under 775.743 Torr; for 48h;97%
With hydrogen; Lindlar's catalyst In 1,4-dioxane
With hydrogen; palladium on activated charcoal In isopropyl alcohol
With hydrogen; palladium on activated charcoal In ethanol
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

Acetic acid (3S,5R,6R,8R,9S,10R,13S,14S)-5,6-dihydroxy-10,13-dimethyl-7,17-dioxo-hexadecahydro-cyclopenta[a]phenanthren-3-yl ester

Acetic acid (3S,5R,6R,8R,9S,10R,13S,14S)-5,6-dihydroxy-10,13-dimethyl-7,17-dioxo-hexadecahydro-cyclopenta[a]phenanthren-3-yl ester

Conditions
ConditionsYield
With osmium(VIII) oxide In pyridine for 2.5h; Ambient temperature;88%
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

3β-acetoxy-17β-hydroxy-5-androsten-7-one
55935-02-9

3β-acetoxy-17β-hydroxy-5-androsten-7-one

Conditions
ConditionsYield
With sodium tetrahydroborate In methanol; ethyl acetate at 0℃; for 0.333333h;82%
With lithium tri(t-butoxy)aluminum hydride In tetrahydrofuran for 0.116667h; Ambient temperature;
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

3β-acetoxy-17a-oxo-androst-5-ene-7,17-dione

3β-acetoxy-17a-oxo-androst-5-ene-7,17-dione

Conditions
ConditionsYield
With peracetic acid; toluene-4-sulfonic acid; acetic acid at 20℃; for 18h; Baeyer-Villiger reaction;67%
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

3β-acetoxyandrostane-7,17-dione

3β-acetoxyandrostane-7,17-dione

Conditions
ConditionsYield
With hydrogen; palladium 10% on activated carbon In ethanol under 760.051 Torr; for 2h;60%
With hydrogen; palladium 10% on activated carbon In ethanol under 760.051 Torr; for 2h;60%
With hydrogen; palladium 10% on activated carbon In ethanol under 760.051 Torr; for 2h;60%
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

3β, 17β-diacetoxyandrost-5-ene-7-one
13209-60-4

3β, 17β-diacetoxyandrost-5-ene-7-one

Conditions
ConditionsYield
With lithium tri-t-butoxyaluminum hydride und anschliessend mit Acetanhydrid;
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

3β-Acetoxy-5-androsten-7α,17β-diol

3β-Acetoxy-5-androsten-7α,17β-diol

Conditions
ConditionsYield
With sodium tetrahydroborate In 1,4-dioxane; ethanol Ambient temperature;
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

3β-acetoxyandrost-5-ene-7β,17β-diol

3β-acetoxyandrost-5-ene-7β,17β-diol

Conditions
ConditionsYield
With sodium tetrahydroborate In 1,4-dioxane; ethanol Ambient temperature;
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

benzoyl chloride
98-88-4

benzoyl chloride

5,7-bisdehydro-3β-acetoxy-17β-benzoyloxy-androstane
123131-09-9

5,7-bisdehydro-3β-acetoxy-17β-benzoyloxy-androstane

Conditions
ConditionsYield
(i) NaBH4 (ii) /BRN= 471389/, Py, (iii) N,N-dimethylaniline; Multistep reaction;
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

3β-Acetoxy-5,17-dioxo-5,7-seco-B-nor-androstan-7-oic acid
87126-22-5

3β-Acetoxy-5,17-dioxo-5,7-seco-B-nor-androstan-7-oic acid

Conditions
ConditionsYield
(i) O3, O2, AcOH, AcOEt, (ii) aq. H2SO4; Multistep reaction;
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

benzoyl chloride
98-88-4

benzoyl chloride

3β-acetoxy-17β-benzoyloxyandrost-5-en-7-one
71583-35-2

3β-acetoxy-17β-benzoyloxyandrost-5-en-7-one

Conditions
ConditionsYield
(i) Li, THF, (ii) /BRN= 471389/, Py; Multistep reaction;
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

5α-androstane-3,7,17-trione
4147-15-3

5α-androstane-3,7,17-trione

Conditions
ConditionsYield
(i) H2, Pd-C, EtOH, (ii) aq. K2CO3, MeOH, (iii) aq. CrO3, H2SO4, acetone; Multistep reaction;
Multi-step reaction with 3 steps
1: H2 / Pd-C / ethanol
2: NaOH / methanol / Heating
3: CrO3, Py
View Scheme
3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

5-androstene-3β-ol-7,17-dione
566-19-8

5-androstene-3β-ol-7,17-dione

Conditions
ConditionsYield
With sodium carbonate In methanol
With sodium hydrogencarbonate In methanol307 mg
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

Phenylselenyl chloride
5707-04-0

Phenylselenyl chloride

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

A

Acetic acid (3S,8R,9S,10R,13S,14S,16R)-10,13-dimethyl-7,17-dioxo-16-phenylselanyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
216484-82-1

Acetic acid (3S,8R,9S,10R,13S,14S,16R)-10,13-dimethyl-7,17-dioxo-16-phenylselanyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

B

Trimethylsilanyl-acetic acid (3S,8R,9S,10R,13S,14S,16R)-10,13-dimethyl-7,17-dioxo-16-phenylselanyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Trimethylsilanyl-acetic acid (3S,8R,9S,10R,13S,14S,16R)-10,13-dimethyl-7,17-dioxo-16-phenylselanyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Conditions
ConditionsYield
With pyridine; water; lithium diisopropyl amide Multistep reaction. Title compound not separated from byproducts;
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

A

Acetic acid (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-7-oxo-17-trimethylsilanyloxy-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Acetic acid (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-7-oxo-17-trimethylsilanyloxy-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

B

Trimethylsilanyl-acetic acid (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-7-oxo-17-trimethylsilanyloxy-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Trimethylsilanyl-acetic acid (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-7-oxo-17-trimethylsilanyloxy-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Conditions
ConditionsYield
With water; lithium diisopropyl amide 1.) THF, hexane, from -78 deg C to RT, 2.) Et2O, 15 min; Multistep reaction. Title compound not separated from byproducts;
Phenylselenyl chloride
5707-04-0

Phenylselenyl chloride

3-O-acetyl-7-oxo-dehydroepiandrosterone
1449-61-2

3-O-acetyl-7-oxo-dehydroepiandrosterone

Acetic acid (3S,8R,9S,10R,13S,14S,16R)-10,13-dimethyl-7,17-dioxo-16-phenylselanyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester
216484-82-1

Acetic acid (3S,8R,9S,10R,13S,14S,16R)-10,13-dimethyl-7,17-dioxo-16-phenylselanyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester

Conditions
ConditionsYield
With pyridine; chloro-trimethyl-silane; tetrabutyl ammonium fluoride; water; lithium diisopropyl amide Yield given. Multistep reaction;

1449-61-2Relevant academic research and scientific papers

Metal-Free Allylic Oxidation of Steroids Using TBAI/TBHP Organocatalytic Protocol

Lam, Ying-Pong,Yeung, Ying-Yeung

, p. 2369 - 2372 (2018)

A mild, efficient and organocatalytic allylic oxidation of steroids using a TBAI/TBHP protocol has been developed. A range of bioactive Δ5-en-7-ones can be easily prepared from the corresponding Δ5-steroids. The methodology features several advantages, including readily available starting materials, environmentally benign oxidant, high functional group compatibility, and metal-free catalysis.

Copper-catalysed allylic oxidation of Δ5-steroids by t-butyl hydroperoxide

Salvador,E Melo,Campos Neves

, p. 119 - 122 (1997)

Δ5-7-Oxosteroids are efficiently prepared from Δ5-steroids with t-BuOOH and a copper catalyst, either Cu(II) and Cu(I) salts or Cu metal; selectivity in the presence of a secondary alcohol is observed.

CrO3/NHPI adsorbed on activated clay: A new supported reagent for allylic selective oxidation of Δ5-sterols

Liu, Jin,Zhu, Hong-You,Cheng, Xiao-Hong

, p. 1076 - 1083 (2009)

Chromium trioxide and N-hydroxyphthalimide (NHPI) supported on activated clay could serve as an efficient and mild oxidant for allylic selective oxidation of Δ5-sterols. Thus, a ketone group could be easily introduced into the allylic position of Δ5-sterols with the existence of a sensitive 3β-hydroxyl group. The oxidant residue can be removed easily from the reaction mixture by filtration and reused after reactivation at 120δC for 4-6 h. Copyright Taylor & Francis Group, LLC.

Recyclable Dirhodium(II) Catalyst Rh2(esp)2 for the Allylic Oxidation of Δ5-Steroids

Wang, Yi,Kuang, Yi,Zhang, Hongyang,Ma, Ruocheng,Wang, Yuanhua

, p. 4729 - 4736 (2017)

The chelating dirhodium(II) catalyst Rh2(esp)2 was shown to efficiently catalyze the allylic oxidation of Δ5-steroids using T-HYDRO (70% tert-butyl hydroperoxide in water) as oxidant. Reaction yields were affected by the coordination ability of the solvent. The noncoordinating solvent n-heptane was determined to be an optimal solvent. At gram scale, the product, Δ5-en-7-one steroid, precipitated from the reaction mixture. The Rh2(esp)2 complex did not undergo catalytic degradation and was recycled using Merrifield-pyridine resin for further allylic oxidation cycles. The results of ultraviolet/visible spectral analysis suggested that the Rh2(II,II) species, rather than the Rh2(II,III) species, was in the catalyst resting state during the reaction, which helps to explain the high durability of the catalyst.

Bismuth-catalyzed allylic oxidation using t-butyl hydroperoxide

Salvador, Jorge A.R.,Silvestre, Samuel M.

, p. 2581 - 2584 (2005)

Bismuth(III) salts are efficient catalysts for the selective allylic oxidation using tert-butyl hydroperoxide. BiCl3 is especially effective and can be easily recovered and reused as BiOCl. Using BiCl 3/K-10 as catalyst, an increase in the reaction rate was observed.

Biohydroxylation of 7-oxo-DHEA, a natural metabolite of DHEA, resulting in formation of new metabolites of potential pharmaceutical interest

?wizdor, Alina,Panek, Anna,Milecka-Tronina, Natalia

, p. 844 - 849 (2016)

Metabolism of steroids in healthy and unhealthy human organs is the subject of extensive clinical and biomedical studies. For this kind of investigations, it is essential that the reference samples of new derivatives of natural, physiologically active steroids (especially those difficult to achieve in the chemical synthesis) become available. This study demonstrated for the first time transformation of 7-oxo-DHEA—a natural metabolite of DHEA, using Syncephalastrum racemosum cells. The single-pulse fermentation of substrate produced two new hydroxy metabolites: 1β,3β-dihydroxy-androst-5-en-7,17-dione and 3β,12β-dihydroxy-androst-5-en-7,17-dione, along with the earlier reported 3β,9α-dihydroxy-androst-5-en-7,17-dione and 3β,17β-dihydroxy-androst-5-en-7-one. Simultaneously, the same metabolites, together with small quantities of 7α- and 7β-hydroxy-DHEA, as well as the products of their reduction at the C-17 were obtained after transformation of DHEA under pulse-feeding of the substrate. The observed reactions suggested that this micro-organism contains enzymes exhibiting similar activity to those present in human cells. Thus, the resulting compounds can be considered as potential components of the eukaryotic, including human, metabolome.

Optimization of the allylic oxidation in the synthesis of 7-keto-Δ5-steroidal substrates

Arsenou, Evaggelia S.,Koutsourea, Anna I.,Fousteris, Manolis A.,Nikolaropoulos, Sotiris S.

, p. 407 - 414 (2003)

A variety of Δ5-steroids were converted into α, β-unsaturated 7-ketones using a modification of the already known method of t-butyl hydroperoxide in the presence of copper iodide in acetonitrile. The same alteration was applied to another oxidative procedure, which had never been used before on steroidal substrates. The same oxidative agent was used in the presence of copper iodide, and tetra-n-butylammonium bromide was used as a phase-transfer catalyst in a two-phase system of water/methylene chloride. It was found that the allylic oxidation proceeded more efficiently when t-butyl hydroperoxide was added to the reaction mixture in portions. The initial addition of the total amount of oxidant or its dropwise addition afforded low yields. This observation contributes to the investigation of the reaction mechanism, and high-yield conversions of steroidal 5,6-enes into the corresponding conjugated 7-ones in short reaction times are reported.

N-Hydroxyphthalimide catalyzed allylic oxidation of steroids with t-butyl hydroperoxide

Zhao, Qian,Qian, Chao,Chen, Xin-Zhi

, p. 1 - 6 (2015)

A new and optimized procedure for the allylic oxidation of Δ5-steroids with t-butyl hydroperoxide in the presence of catalytic amounts of N-hydroxyphthalimide (NHPI) under mild conditions was developed, showing excellent regioselectivity and chemoselectivity (functional group compatibility). It was found that Co(OAc)2 could enhance the catalytic ability of NHPI resulting in better yields and shorter reaction times. The reaction mechanism and the scope of the reaction with a variety of Δ5-steroidal substrates were also investigated.

Visible-Light-Enabled Allylic C-H Oxidation: Metal-free Photocatalytic Generation of Enones

Liu, Chao,Liu, Hui,Zheng, Xuan,Chen, Shanyi,Lai, Qihong,Zheng, Changlong,Huang, Mingqiang,Cai, Kaicong,Cai, Zhixiong,Cai, Shunyou

, p. 1375 - 1381 (2022/02/07)

A practical and efficient method has been established for the direct oxidation of allylic C-H bonds catalyzed by visible-light-enabled photoredox agents. This protocol uses oxygen as the sole oxidant under metal-free conditions at room temperature and pro

Iridium-catalysed highly selective reduction-elimination of steroidal 4-en-3-ones to 3,5-dienes in water

Li, Jide,Tang, Weiping,Ren, Demin,Xu, Jiaxi,Yang, Zhanhui

supporting information, p. 2088 - 2094 (2019/04/29)

Steroidal 3,5-diene is an important structural motif in steroid drugs. In this report, an iridium-catalyzed reduction-elimination of readily available steroidal 4-en-3-ones is realized to prepare steroidal 3,5-dienes. At a low catalyst loading (S/C = 200), heating 4-en-3-ones in a water-mixed organic solvent with formic acid without inert atmosphere protection afforded the desired 3,5-dienes in moderate to excellent yields. In a gram-scale preparation, recrystallization is used instead of column chromatography to purify products. Excellent functionality tolerance and regioselectivity are featured. Structural moieties such as alkanols (primary, secondary and tertiary), esters (except for formate), tolylates, and ketones (endocyclic or exocyclic) are not affected. Surprisingly, the reduction-elimination only takes place at A-ring 4-en-3-ones. In addition, bicyclic 4-en-3-ones are also viable substrates. Synthetic applications of steroidal 3,5-dienes are demonstrated. Our method can also lead to steroidal 3,5-dienes-3-d (>99% d-incorporation) when DCO2D and D2O are used together.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1449-61-2